13
Total investments
2
Early stage
1
Mid stage
3
Late stage
19y
Years active
Portfolio
8 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Ex-Board Member
Jun 2016
Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster.
We are targeting the growing need for throughput with robust solutions for clinical and large-scale proteomics, and we have a very ambitious business plan to bring the community closer to the clinic.
We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.
Non Executive Board Member
Dec 2013
TeesuVac is developing a new efficient handheld vacuum-assisted biopsy gun, for taking precise core biopsy samples of tissue, which on examination by pathologist can help detect diseases and to which extent they have developed.
The company was incorporated in 2013 and is based in Aarhus and Hørsholm, Denmark.
S
EX- Board Member
Sep 2010
Sense A/S is dedicated to the development of a novel medical device for accurate, non-invasive, non-interfering measurement of blood pressure.
Despite the fact that blood pressure determination continues to be one of the most important measurements in all of clinical medicine it is still one of the most inaccurately performed.
One of the biggest problems with current devices is that the device itself and the circumstances under which measurements are made may have a strong impact on the result. The measurement procedure is also rather uncomfortable especially during continuous measurements.
Ex-Board Member
Jul 2010
Medotech A/S is a danish medtech company. Medotech's main product GRINDCARE is a device for management of bruxism (toothgrinding).
Ex-Board Member
Jun 2009
Medical Insight A/S is an innovative Danish company, founded in 2001, that specializes in making Healthcare Imaging completely Mobile. The EasyViz product meets the fast-growing market demands for wireless infrastructures and mobile workflows by extending the reach of any PACS system into the wireless/mobile arena without sacrificing functionality or speed. EasyViz is highly scalable and is used in large regional multi-hospital environments, as well as in small imaging centers.
Medical Insight A/S was acquired June 2014 by Karos Health. By combining EasyViz with the proven standards-based clinical information exchange, archiving and cross-enterprise workflow solutions from Karos Health, we can now provide users with access to diagnostic imaging and non-DICOM information from all departments and across enterprises. Our product has always been designed to help you gain easy and fast access to imaging information when and where needed. By joining Karos Health, we are able to do that better than ever.
For future information on Medical Insight A/S, please see: http://www.karoshealth.com/
Ex-Board member
2008
AnyBody Technology develops and markets the #1 CAE software for musculoskeletal biomechanics.
AnyBody Technology also provides consultancy, training courses and technical support to users and services clients.
The AnyBody Modeling System is a breakthrough invention for simulating body-device, man-machine or other man-environment interaction and how it effects the human body.
Key markets for the products and the services of AnyBody Technology are the global orthopaedics, automotive, aerospace, assistive devices, and sports equipment industries. Users of the AnyBody Modeling System are mainly involved in either university research, or R&D activities in the industries.
Ex-Board Member
Jun 2007
Proxeon develops state-of-the-art solutions to solve many of the scientific and technical challenges that are faced by those working in the field of proteomics. The company is committed to making a positive difference to the success of researchers throughout the world by providing high performance and innovative solutions for medical, pharmaceutical and biotech research.
The proteomics field draws on a wide range of knowledge, including biology, physics, engineering and informatics. Scientists at Proxeon have been actively involved in proteomics research for more than 15 years and have a proven track record in development of high quality products. Their expert knowledge in the field enables them to develop products that address key bottlenecks in proteomic workflows and provide superior performance, robustness, simplicity and user-friendliness.
With core competencies in the areas of mass spectrometry, protein analysis, hardware and software design for proteome analysis, Proxeon is uniquely capable of developing superior solutions, and creating a new generation of powerful proteomics tools.
Experience · 19 entries
All (19)
Investments (13)
Founder (1)
Board (13)
2025
Board Member
Apr 2025
At Celvivo, we’re on a mission to help scientists push the frontiers of 3D cell culture.
Our Clinostat-based technology enables cells in vitro to recover lost physiological attributes, re‑establish intercellular communication, and perform more like they do in vivo - Whether you work with spheroids or organoids.
We designed the Celvivo Clinostar and ClinoReactor on four core principles: 3D cell culture should be relevant, abundant, easy‑to‑use, and reproducible.
In close collaboration with researchers worldwide, we’re solving long‑standing challenges like active diffusion bias and shear stress, so your models can be more predictive and more meaningful.
Friendly, nerdy, premium, and pioneering - that’s who we are. And with the most user‑friendly system for organoids yet, we invite you to join us in shaping the future of 3D cell culture based research.
Celvivo
Refine your research
2021
Partner
Apr 2021
Denmark´s Export and Investment fund is a new, state-owned fund which proves a single point of contact to all Danish companies in need of state financed risk capital. We cover both the entrepreneur, small and medium-sized companies who need capital to unfold their full potential, and export companies who wish to conquer new or emerging markets. We can guide you all the way, from the company´s tentative beginnings through substantial growth to entry into the global markets with export guarantees and stock market listings, because our mission is to help to grow the Danish economy and green the globe.
2017
Member Of The Board Of Directors
Oct 2017
MicroShade A/S is a Danish technology and knowledge-based company that develops and markets advanced, transparent solar shading solutions for new and refurbished buildings. The company produces and sells unique, proprietary films to glazing manufacturers, who assemble them into standard glazing units and supply these to the building industry.
MicroShade® is a breakthrough in solar shading that is integrated into facade glazing. The new green technology solves the challenges of solar shading with a low-carbon footprint, while ensuring people’s well-being and
reducing the total cost of ownership.
Environmental impact
Reduces the CO2 footprint in the construction phase by only requirering 0,24kg/m2 in material use.
No extra installation requirements as it is built into the glazing as a passive solution.
Reduces the CO2 footprint in the operation phase by providing effective shading that minimizes the use of cooling.
Zero operation and maintenance cost.
Social impact
Provides efficient shading, creating a good indoor environment with pleasant temperatures and a limited amount of direct solar beam.
Reduces glare whilst allowing natural daylight.
Allows for a clear view out at all times, leaving an unobstructed view.
The above-mentioned factors lead to increased well-being and a better work environment.
Economic impact
Low total cost of ownership (TCO).
Low installation cost, requires no maintenance or operation costs.
Product lifetime aligned with that of the window.
2016
Ex-Board Member
Jun 2016
Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster.
We are targeting the growing need for throughput with robust solutions for clinical and large-scale proteomics, and we have a very ambitious business plan to bring the community closer to the clinic.
We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.
2013
Non Executive Board Member
Dec 2013
TeesuVac is developing a new efficient handheld vacuum-assisted biopsy gun, for taking precise core biopsy samples of tissue, which on examination by pathologist can help detect diseases and to which extent they have developed.
The company was incorporated in 2013 and is based in Aarhus and Hørsholm, Denmark.
Show all 19 entries ↓
Investment activity
2007–2025 · 13 investments
Recent (last 2 years)Earlier
